C. auris post-COVID-19: Updates on antifungal resistance, lessons learned and more

Noon - 1 p.m.

This event is open to HANYS members and non-members.

This session will discuss challenges in testing for and treating C. auris, including the recent development of echinocandin and pan-resistant isolates. Broader C. auris trends during and after the COVID-19 surge will be explored, and presenters will review lessons learned from the public health and infection prevention and control response.

After the webinar, participants will be able to:

• describe antifungal resistance trends in C.auris;
• discuss treatment of C.auris;
• explain epidemiological trends in C. auris, including during and post-COVID-19 waves; and
• discuss lessons learned in infection prevention and control of C. auris within healthcare facilities.

This webinar is part of HANYS’ Commitment to Excellence Emerging Quality Trends Series. Each session will cover a different cutting-edge topic to expand healthcare providers' clinical expertise and share proven best practices to deliver high-quality care. For more information about this program, contact Erin Gretzinger, CPHQ, director, Quality Advocacy, Research, and Innovation, at 518.431.7744 or egretzin@hanys.org.

If you have questions regarding registration, please contact Registration Support at learning@hanys.org or 518.431.7867